Oxler Private Wealth’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,000
Closed -$47.4K 459
2022
Q2
$47.4K Buy
+8,000
New +$89K 0.02% 152
2022
Q1
Sell
-8,000
Closed -$261K 115
2021
Q4
$261K Hold
8,000
0.11% 110
2021
Q3
$328K Buy
8,000
+2,000
+33% +$72.6K 0.14% 108
2021
Q2
$216K Buy
+6,000
New +$221K 0.09% 123
2021
Q1
Sell
-2,000
Closed -$80K 158
2020
Q4
$80K Buy
+2,000
New +$91.9K 0.05% 141

Other funds holding GDRX

Oxler Private Wealth's GDRX Position: Q3 2022 in Review

Oxler Private Wealth sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 8,000 shares — an estimated $47.4K sold.

Oxler Private Wealth first reported a position in GDRX in Q4 2020 and held it in 5 quarters. The position peaked at $328K in Q3 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

  • Oxler Private Wealth reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
  • Oxler Private Wealth sold 8,000 GoodRx Holdings shares in Q3 2022, an estimated $47.4K.
  • Oxler Private Wealth first reported a position in GoodRx Holdings in Q4 2020 and held it in 5 quarters.
  • Oxler Private Wealth's GoodRx Holdings position peaked at $328K in Q3 2021.
  • 180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on Oxler Private Wealth's 13F filing for Q3 2022, filed 15 Nov 2022.